Patient-derived Xenograft (PDX) Modeling of Treatment Response for Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
- Status
- COMPLETED
- Phase
- PHASE3
A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
RX-5902 Treatment of Subjects With Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cisplatin vs Paclitaxel for Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
cMet CAR RNA T Cells Targeting Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment
- Status
- COMPLETED
- Phase
- PHASE1
Tivozanib in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1b Trial of Dinaciclib With Pembrolizumab for Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Study - Aurora + Angiogenic Kinase Inhibitor ENMD-2076 in Previously Treated Locally Advanced + Metastatic TNBC
- Status
- COMPLETED
- Phase
- PHASE2
Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
- Status
- COMPLETED
- Phase
- PHASE1
A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
- Status
- COMPLETED
- Phase
- PHASE1